Literature DB >> 26851588

Potential novel markers to discriminate between active and latent tuberculosis infection in Chinese individuals.

Xue-juan Bai1, Yan Liang2, You-rong Yang2, Jin-dong Feng3, Zhan-peng Luo4, Jun-Xian Zhang2, Xue-qiong Wu5.   

Abstract

Latent tuberculosis infection (LTBI) constitutes the main reservoir for reactivation tuberculosis. The finding of potential biomarkers for differentiating between TB and LTBI is very necessary. In this study, the immunological characteristics and potential diagnostic utility of Rv2029c, Rv2628 and Rv1813c proteins were assessed. These three proteins stimulated PBMCs from ELISPOT-positive LTBI subjects produced higher levels of IFN-γ in comparison with TB patients and ELISPOT-negative healthy subjects (p<0.05). BCG vaccination and non-TB respiratory disease had little influence on the immunological responses of Rv2029c and Rv2628 proteins (p>0.05). The LTBI diagnostic performance of Rv2029c was higher than Rv2628 and Rv1813c by ROC evaluation. But Rv2628 had much higher specificity than Rv2029c in active TB patients and uninfected healthy subjects. The IgG level against Rv1813c was higher in the TB group than in LTBI and uninfected healthy subjects (p<0.05). These results suggest that T cell response to Rv2628 and antibody against Rv1813c might be applicable as biomarkers to distinguish TB from LTBI and uninfected individuals.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Diagnosis; Latent tuberculosis infection; Mycobacterium tuberculosis; Rv1813c; Rv2029c; Rv2628; Tuberculosis

Mesh:

Substances:

Year:  2015        PMID: 26851588     DOI: 10.1016/j.cimid.2015.11.002

Source DB:  PubMed          Journal:  Comp Immunol Microbiol Infect Dis        ISSN: 0147-9571            Impact factor:   2.268


  6 in total

1.  Potential of DosR and Rpf antigens from Mycobacterium tuberculosis to discriminate between latent and active tuberculosis in a tuberculosis endemic population of Medellin Colombia.

Authors:  Leonar Arroyo; Diana Marín; Kees L M C Franken; Tom H M Ottenhoff; Luis F Barrera
Journal:  BMC Infect Dis       Date:  2018-01-08       Impact factor: 3.090

2.  Diagnostic performance and problem analysis of commercial tuberculosis antibody detection kits in China.

Authors:  Xue-Juan Bai; You-Rong Yang; Jian-Qin Liang; Hui-Ru An; Jie Wang; Yan-Bo Ling; Zhong-Yuan Wang; Xue-Qiong Wu
Journal:  Mil Med Res       Date:  2018-03-22

3.  A Systematic Review on Novel Mycobacterium tuberculosis Antigens and Their Discriminatory Potential for the Diagnosis of Latent and Active Tuberculosis.

Authors:  Noëmi R Meier; Marc Jacobsen; Tom H M Ottenhoff; Nicole Ritz
Journal:  Front Immunol       Date:  2018-11-09       Impact factor: 7.561

4.  Two-Hit in vitro T-Cell Stimulation Detects Mycobacterium tuberculosis Infection in QuantiFERON Negative Tuberculosis Patients and Healthy Contacts From Ghana.

Authors:  Ernest Adankwah; Christian Lundtoft; Alptekin Güler; Kees L M C Franken; Tom H M Ottenhoff; Ertan Mayatepek; Ellis Owusu-Dabo; Richard Odame Phillips; Norman Nausch; Marc Jacobsen
Journal:  Front Immunol       Date:  2019-07-03       Impact factor: 7.561

5.  Enhanced serodiagnostic potential of a fusion molecule consisting of Rv1793, Rv2628 and a truncated Rv2608 of Mycobacterium tuberculosis.

Authors:  Sadaf Sulman; Saher Shahid; Aasia Khaliq; Atiqa Ambreen; Imran H Khan; Andrea M Cooper; Muhammad Waheed Akhtar
Journal:  PLoS One       Date:  2021-11-12       Impact factor: 3.240

6.  Microarray-based selection of a serum biomarker panel that can discriminate between latent and active pulmonary TB.

Authors:  Zhihui Li; Jianjun Hu; Pengchong Liu; Dan Cui; Hongqin Di; Shucai Wu
Journal:  Sci Rep       Date:  2021-07-15       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.